PDT Partners’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-69,900
Closed -$1.29M – 596
2017
Q3
$1.29M Buy
69,900
+19,296
+38% +$334K 0.04% 329
2017
Q2
$838K Buy
+50,604
New +$704K 0.03% 357

Other funds holding ENTL

PDT Partners's ENTL Position: Q4 2017 in Review

PDT Partners sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q4 2017, closing a stake of 69,900 shares — an estimated $1.29M sold.

PDT Partners first reported a position in ENTL in Q2 2017 and held it in 2 quarters. The position peaked at $1.29M in Q3 2017. 83 funds tracked by Wall St. Rank hold ENTL as of Q4 2017.

  • PDT Partners reported no remaining Entellus Medical, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • PDT Partners sold 69,900 Entellus Medical, Inc. Common Stock shares in Q4 2017, an estimated $1.29M.
  • PDT Partners first reported a position in Entellus Medical, Inc. Common Stock in Q2 2017 and held it in 2 quarters.
  • PDT Partners's Entellus Medical, Inc. Common Stock position peaked at $1.29M in Q3 2017.
  • 83 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2017.

Based on PDT Partners's 13F filing for Q4 2017, filed 14 Feb 2018.